CBD GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Gets EU Approval U.S. Epidiolex sales have surged on strong patient uptake and now the CBD-based epilepsy drug could be sold in 31 European countries after EU... Jared GnamSeptember 24, 2019
CBD GW Pharma Doubles Sales on Strong Uptake of CBD Drug Epidiolex Analysts have been bullish on the U.K. drugmaker raising estimates and price targets after its second-quarter sales easily surpassed expectations. David JAugust 22, 2019